PF-429242

N/A

Report date: 2024/12/04 15:18:03

NME

Base Information

Drug NamePF-429242

Drug Alias NamePF-429242

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMembrane-bound transcription factor site-1 protease inhibitorsFatty acid synthase inhibitors

TargetsMembrane-bound transcription factor site-1 proteaseFatty acid synthase

Therapy Area/IndicationsHyperlipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHyperlipidemias

ATC CodeN/A